1.Wertheim HF, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 2005; 5: 751–762.
2.Wertheim HF, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004; 364: 703–705.
3.Muder RR, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Annals of Internal Medicine 1991; 114: 107–112.
4.Mest DR, et al. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesthesia & Analgesia 1994; 78: 644–650.
5.Chang FY, et al. Staphylococcus aureus nasal colonization in patients with cirrhosis: prospective assessment of association with infection. Infection Control and Hospital Epidemiology 1998; 19: 328–332.
6.Ellis MW, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clinical Infectious Diseases 2004; 39: 971–979.
7.Bradley SF, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Annals of Internal Medicine 1991; 115: 417–422.
8.Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666–674.
9.King MD, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine 2006; 144: 309–317.
10.Johnson JK, et al. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerging Infectious Diseases 2007; 13: 1195–1200.
11.Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763–1771.
12.Miller LG, Diep BA. Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clinical Infectious Diseases 2008; 46: 752–760.
13.Frazee BW, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Annals of Emergency Medicine 2005; 45: 311–320.
14.Kazakova SV, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. New England Journal of Medicine 2005; 352: 468–475.
15.Shurland SM, et al. Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infection Control and Hospital Epidemiology 2009; 30: 313–318.
16.Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128–1132.
17.Diep BA, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367: 731–739.
18.Harmsen D, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. Journal of Clinical Microbiology 2003; 41: 5442–5448.
19.Kreisel KM, et al. Illicit drug use and risk for USA300 methicillin-resistant Staphylococcus aureus infections with bacteremia. Emerging Infectious Diseases 2010; 16: 1419–1427.
20.McGeer A, et al. Definitions of infection for surveillance in long-term care facilities. American Journal of Infection Control 1991; 19: 1–7.
21.Deyo R, Cherkin D, Ciol M. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology 1992; 45: 613–619.
22.Roghmann MC, et al. MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. Journal of Hospital Infection 2001; 47: 98–103.
23.Pujol M, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. American Journal of Medicine 1996; 100: 509–516.
24.Davis KA, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clinical Infectious Diseases 2004; 39: 776–782.
25.Yang ES, et al. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clinical Microbiology and Infection 2010; 16: 425–431.
26.Peters PJ, et al. Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture. Epidemiology and Infection 2011; 139: 998–1008.
27.Gorwitz RJ, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. Journal of Infectious Diseases 2008; 197: 1226–1234.
28.Diep BA, et al. The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. Journal of Infectious Diseases 2008; 197: 1523–1530.
29.Ellis MW, et al. Presence and molecular epidemiology of virulence factors in methicillin-resistant Staphylococcus aureus strains colonizing and infecting soldiers. Journal of Clinical Microbiology 2009; 47: 940–945.
30.Schechter-Perkins EM, et al. Prevalence and predictors of nasal and extranasal staphylococcal colonization in patients presenting to the emergency department. Annals of Emergency Medicine 2011; 57: 492–499.